GlassScriptPhysician profile
Kelly Strimaitis
NPI 1194391607
$1,702.77
in general payments reported to CMS, 2019-2025
17 companies · $622 in 2025
The $622 reported for 2025 was more than what 79% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $37.92 · 2022: $185 · 2023: $518 · 2024: $340 · 2025: $622.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,480.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,479.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $430.16 | 2022-2025 | Dupixent |
| Inspire Medical Systems, INC. | $260.75 | 2023-2025 | Inspire |
| Genzyme Corporation | $180.02 | 2023-2025 | |
| Glaxosmithkline, LLC. | $174.03 | 2023-2025 | Nucala |
| Novartis Pharmaceuticals Corporation | $163.91 | 2022-2024 | |
| Kaleo, INC. | $96.19 | 2021-2024 | Auvi-Q |
| Optinose US, INC. | $72.42 | 2022-2025 | |
| Genentech USA, INC. | $45.90 | 2024-2025 | Xolair |
| Astrazeneca Pharmaceuticals LP | $43.63 | 2023-2025 | Tezspire, Airsupra, Fasenra |
| Alk-Abello, INC | $43.31 | 2021-2025 | Timothy, Standardized, Alternaria Tenuis, Pre-Pen |
| Ars Pharmaceuticals Operations, INC. | $42.75 | 2025 | Neffy |
| Stryker Corporation | $42.33 | 2023 | Xpress Ent Dilation System |
| Smith+Nephew, INC. | $29.69 | 2024 | Tula |
| Hologic Sales and Service, LLC | $21.39 | 2023 | Coolseal Generator |
| Paratek Pharmaceuticals, INC. | $19.39 | 2025 | Nuzyra |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $19.26 | 2025 | Perclot |
| Hikma Pharmaceuticals USA | $17.64 | 2025 | Ryaltris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelly Strimaitis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.